FDA Approves ENDOCET — Par Health USA, LLC

Par Health USA, LLC received FDA approval for the ANDA 040330 to market ENDOCET (oxycodone hydrochloride and acetaminophen), a generic option for the oral pain medication. This approval adds to the competitive landscape of opioid combination therapies, potentially impacting market share for branded and alternative generic versions.